84218-68-8 Usage
Uses
Used in Organic Synthesis:
ALLYL-2,3-DI-O-BENZYL-BETA-D-GLUCOPYRANOSIDE is used as a key intermediate in organic synthesis for the construction of complex organic molecules. Its unique structure allows for versatile chemical reactions, facilitating the synthesis of a wide range of compounds.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, ALLYL-2,3-DI-O-BENZYL-BETA-D-GLUCOPYRANOSIDE is utilized as a building block for the development of pharmaceuticals. Its structural features make it a valuable component in the design and synthesis of new drugs with potential therapeutic applications.
Used in Pharmaceutical Industry:
ALLYL-2,3-DI-O-BENZYL-BETA-D-GLUCOPYRANOSIDE is used as a precursor in the pharmaceutical industry for the synthesis of drugs with potential anti-inflammatory and anti-cancer properties. Its incorporation into drug molecules can enhance their therapeutic effects and contribute to the development of novel treatments for various diseases.
Used in Research and Development:
ALLYL-2,3-DI-O-BENZYL-BETA-D-GLUCOPYRANOSIDE is also used in research and development settings to explore its pharmacological properties further. Studies on ALLYL-2,3-DI-O-BENZYL-BETA-D-GLUCOPYRANOSIDE aim to understand its mechanisms of action and evaluate its potential as a therapeutic agent, thereby expanding its applications in medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 84218-68-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,4,2,1 and 8 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 84218-68:
(7*8)+(6*4)+(5*2)+(4*1)+(3*8)+(2*6)+(1*8)=138
138 % 10 = 8
So 84218-68-8 is a valid CAS Registry Number.
84218-68-8Relevant academic research and scientific papers
COMPOUND RETAINED IN TUMOR
-
, (2011/12/03)
A novel compound which specifically resides in a tumor, a method for allowing it to reside in a tumor, and a method for detecting, diagnosing, and treating tumor with use thereof are provided. The present invention relates to a compound represented by chemical formula (I) wherein R is an anionic group binding to hydrogen, R1 is OH, OCOH, OCO(CH2)hCH3, or an acting group, h being an integer of 0 or more, R2 is H, OH, OCOH, OCO(CH2)iCH3, or an acting group, i being an integer of 0 or more, R3 is OH, SO3H, or an acting group, R4 is OH, SO3H, or an acting group, and R5 is OH, SO3H, or an acting group, at least one of R1, R2, R3, R4, and R5 containing an acting group, or pharmaceutically acceptable salts thereof.
SYNTHESIS OF SULFATED GLYCOHEXAOSE OF LINKAGE REGION OF CHONDROITIN 4-SULFATE: β-D-GlcA-(1->3)((SO3Na->4))-β-D-GalNAc-(1->4)-β-D-GlcA-(1->3)-β-D-Gal-(1->3)-β-D-Gal-(1->4)-D-Xyl
Goto, Fumitaka,Ogawa, Tomoya
, p. 6841 - 6844 (2007/10/02)
Stereocontrolled synthesis of glycohexaoses 3 and 4 which corresponds to the linkage region of chondroitin 4-sulfate to a core protein was achieved for the first time by employing glycotriosyl donor 5 and glycotriosyl acceptor 6.
Synthetic Studies on Rhynchosporoside and Related Substances
Sugawara, Fumio,Nakayama, Haruhiko,Strobel, Gary A.,Ogawa, Tomoya
, p. 2251 - 2260 (2007/10/02)
The stereoselective synthesis of the 1-O-α-D-glucopyranosides and 1-O-α-D-cellobiosides of 3-deoxy-2(R)- and 2(S)-glycerols to determine the complete stereochemistry of rhynchosporoside, which is a host selective phytotoxin from Rhynchosporium secalis, is